Search results
Focus on Eyes: Macular degeneration can be scary but options exist to slow it down
Florida Today via Yahoo News· 1 year agoSupport local journalism. A digital subscription is incredibly affordable and makes you the most...
What Is Macular Degeneration?
Health via Yahoo News· 1 year agoMacular degeneration, often known as age-related macular degeneration, is a progressive eye disease that makes things blurry in the center of your vision. Most people develop macular degeneration ...
What Is Wet Age-Related Macular Degeneration (Wet AMD)?
Health via Yahoo News· 5 months agoWet age-related macular degeneration (AMD), or advanced neovascular AMD, is an eye condition...
Focus on Eyes: Advancements in macular degeneration, thyroid eye disease, eye infection treatment
Florida Today via Yahoo News· 4 months agoThere have been tremendous advances in treatment of several significant eye diseases, including...
Neovascular Age-Related Macular Degeneration (AMD): What to Know
Verywell Health via Yahoo News· 3 months agoUnderstanding Blood Vessel Formation in Wet AMD Medically reviewed by Christine L. Larsen, MD...
Managing Age-Related Macular Degeneration (AMD) Vision Loss
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Bryan M. Wolynski, OD Age-related macular degeneration (AMD) is the most...
Wet AMD Treatment
Verywell Health via Yahoo News· 4 months agoLong-term treatments for late-stage damage remain a research priority Medically reviewed by Christine L. Larsen, MD Wet AMD (age-related macular...
Biotech Giant Regeneron Hit As Eylea Gives Ground To Avastin
Investor's Business Daily· 1 year agoBiotech giant Regeneron Pharmaceuticals said Monday that sales of its linchpin Eylea drug in the...
Newly-Approved High Dose Eylea Cuts Down on Injection Frequency
Verywell Health via Yahoo News· 8 months agoThe Food And Drug Administration approved a higher dose of Eylea, a drug used to treat wet...
Regeneron (REGN) Down on Ophthalmology Drug Eylea Sales Update
Zacks via Yahoo Finance· 1 year agoShares of Regeneron Pharmaceuticals, Inc. REGN were down 7.69% after the company announced that its...